Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
11.47
-0.09 (-0.78%)
At close: Apr 28, 2025, 4:00 PM
11.03
-0.44 (-3.84%)
Pre-market: Apr 29, 2025, 4:01 AM EDT
Nurix Therapeutics Analyst Ratings
Total Analysts
17
Consensus Rating
Strong Buy
Price Target
$30.71
Upside
+167.74%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $32 → $25 | Buy | Maintains | $32 → $25 | +117.96% | Apr 9, 2025 |
| Stifel | Stifel | Strong Buy Maintains $36 → $35 | Strong Buy | Maintains | $36 → $35 | +205.14% | Apr 9, 2025 |
| Needham | Needham | Strong Buy Maintains $28 → $27 | Strong Buy | Maintains | $28 → $27 | +135.40% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +213.86% | Apr 2, 2025 |
| Leerink Partners | Leerink Partners | Hold Initiates $16 | Hold | Initiates | $16 | +39.49% | Mar 17, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +48.21% | Feb 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $26 → $27 | Buy | Maintains | $26 → $27 | +135.40% | Jan 29, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +161.55% | Jan 29, 2025 |
| Stifel | Stifel | Strong Buy Maintains $34 → $36 | Strong Buy | Maintains | $34 → $36 | +213.86% | Jan 29, 2025 |
| Needham | Needham | Strong Buy Maintains $29 → $28 | Strong Buy | Maintains | $29 → $28 | +144.12% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $36 | Strong Buy | Maintains | $35 → $36 | +213.86% | Jan 29, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $31 | Buy | Reiterates | $31 | +170.27% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $35 | Strong Buy | Maintains | $30 → $35 | +205.14% | Dec 11, 2024 |
| BTIG | BTIG | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +205.14% | Dec 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +152.83% | Dec 10, 2024 |
| BMO Capital | BMO Capital | Buy Initiates $35 | Buy | Initiates | $35 | +205.14% | Dec 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.